Szalai Eszter Ágnes, Teutsch Brigitta, Babay Viktória, Galvács Adél, Hegyi Péter, Hársfalvi Péter, Pál Róbert, Varga Gábor, Lohinai Zsolt M, Kerémi Beáta
Department of Restorative Dentistry and Endodontics, Semmelweis University, Budapest, Hungary.
Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.
BDJ Open. 2024 May 20;10(1):35. doi: 10.1038/s41405-024-00221-8.
Intra-oral halitosis (IOH) is the most common type of bad breath; its consequences impair quality of life. However, evidence-based treatment protocols and guidelines are lacking. Our aim is to investigate the effectiveness of chlorine dioxide as an applicable complementary treatment modality in IOH after tongue cleaning.
The ODOR trial will be a single-center, double-blinded, parallel-group, double-armed pilot randomized controlled trial with a non-inferiority design. The efficacy of hyperpure chlorine dioxide will be compared to chlorhexidine mouthwash. We plan to investigate the short-term effects of the intervention over a 3-h period. The primary endpoint will be changes in organoleptic test scores. At the end of the pilot investigation of the first 30 patients each, sample size calculation will be performed. If feasible, the investigators will continue the study by enrolling more patients.
The trial has been registered at ClinicalTrials.gov (NCT06219226).
口腔内口臭(IOH)是最常见的口臭类型;其后果会损害生活质量。然而,缺乏基于证据的治疗方案和指南。我们的目的是研究二氧化氯作为舌清洁后IOH适用的辅助治疗方式的有效性。
ODOR试验将是一项单中心、双盲、平行组、双臂先导随机对照试验,采用非劣效性设计。将超纯二氧化氯的疗效与洗必泰漱口水进行比较。我们计划在3小时内研究干预措施的短期效果。主要终点将是感官测试分数的变化。在对每组前30名患者进行先导研究结束时,将进行样本量计算。如果可行,研究人员将通过招募更多患者继续该研究。
该试验已在ClinicalTrials.gov(NCT06219226)注册。